ESPE Abstracts (2019) 92 P1-313

ESPE2019 Poster Category 1 Diabetes and Insulin (2) (26 abstracts)

Familial Versus Non-Familial Type-2 Diabetes Mellitus in Children and Adolescents: Clinical and Biochemical Data.

Fawzia Alyafei , Ashraf Soliman , Aml Sabt & Nagwa Aldarsy

hamad general hospital, doha, Qatar

Familial clustering of type-2 diabetes is well-known. In adults, the prevalence of diabetes is higher among patients with diabetic parents. The Framingham offspring study found that maternal and paternal diabetes conferred equal risk for offspring type-2 diabetes.

Objectives: We conducted this study to compare the clinical characteristics of children and adolescents with family history of type- 2 diabetes mellitus, in one or both parents, (FT2DM) with those without a family history of DM (NFT2DM).

Patients and Methods: This was a cross-sectional descriptive study to determine the clinical presentation and prevalence of beta cell autoimmunity (Anti GAD, anti-islet cell and anti-insulin antibodies), thyroid function (Free thyroxine (FT4) and TSH) and anti-thyroid peroxidase antibody (ATPO) and anti-tissue transglutaminase (ATT) in a randomly selected cohort of children and adolescent (< 16 years) with FT2DM ( n= 13) and compare them with those for children without family history of DM (NFT21DM ( n = 26) at their first presentation at Hamad General Hospital Diabetes Center, Doha, Qatar

Conclusion: In this study, FT2DM occurred more in males than females, after 10 years of age, and all presented with hyperglycemia without ketosis. Clinical and subclinical hypothyroidism occurred more in the NFT2DM and they had a higher prevalence of hypercholesterolemia and triglyceridemia.

Familial DiabetesNFT2DMFMT2DM
Prevalence of beta-cell autoimmunity
Islet cell AB29.4 %42.85 %*
Insulin AB58.3 %50 %
Anti-GAD +ICA28.3 %0%
Prevalence of thyroid disorder
1-T4 (<11)11.5 %*0%
2-TSH (5.6-10)8%8.3 %
3-TSH (>10)6 %8.3 %
4-TPO (>100)34.6%30%
5-TPO (>100 )+ NL TFT23.1%20%
6-TPO (>100)+ hypothyroid ( T4 <11 ) or TSH >10)7.7%*0%
7-TPO (>100)+ subclinical (TSH 5.6-10)3.8 %*0%
1-ATT IgA>108.7 %*0%
2-ATT Igg >100%0%
1-PH <7.32.63%*0%
2-Hco3 <152.6%*0%
2-Male39.2%61.54 %*
Age years
0 to 40%0%
5 to 924.14%*0%
10 to 1475.68%100%*
1. high ALT46.34%46.2%
2. high AST24.39%*7.69%
3. high ALP12.8%7.69%
Lipid profile
High LDL10.26 % 0%
Low HDL (low)43.589%55.5%
High Cholesterol5.13%*0%
High Triglycerides17.9 %*10%

Volume 92

58th Annual ESPE

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.